IVX 50.0% 0.3¢ invion limited

Ann: Appendix 4C - December 2019 quarter, page-7

  1. 78 Posts.
    lightbulb Created with Sketch. 3
    And it's not a recent situation, it has been funded for years.Compared to previous months it seems to hold above .010 , as sell sentiment diminished influenced by the fact that whoever has followed this over the years doesn't really want to miss the human trial announcements:
    "As previously announced to the market, Invion will be commencing Phase 1b human trials of
    IVX-PDT to treat skin cancer, while Peter MacCallum Cancer Institute will be commencing
    studies using IVX-PDT for the treatment of ano-genital cancer in 2020. "

    They made progress in the past 2 years releasing positive progress with no failures every 3/6 months.So they make give us something late Q1/start Q2, or even before.
    Once they begin the human trials there will be no turning back . But by all means, I really don't want to be to positive as I'm still accumulating .

    DYOR Boys and girls!
 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.